Abstract
Investigation of adiponectin levels andintracardiac haemodynamic statehas been done in 96 patients divided into two groups (1st group – 64 hypertensive (stage II) overweight patients, medium age 59,0 (48,0–63,0) years; 2-nd group – 32 hypertensive (stage II) patients, medium age 58,0 (53,0–63,0) years, normal weight). Dependences between the left auricle size, blood pressure, and BMI increase, as well as between the left ventricle remodelling character and BMI in the surveyed patients were uncovered. Theconcentric left ventricle hypertrophy observed in the surveyed patients was characterised by normal contractility, leftventricle posteriorwall relative thickness increase, and normal or reduced end-diastolic volume. The blood serum adiponectin level in hypertensive (stage ІІ) overweight patients was significantly (nearly 3 times) lower as compared to the group of hypertensive (stage ІІ) patients who had normal weight.
Publisher
Zaporizhia Medical Academy of Post-Graduate Education
Reference16 articles.
1. Ametov AS, Pashkova EY, Ramazanova ZD, Darsigova MN Obesity as a non-infectious epidemic of the 21st century. Current ideas about pathogenesis, risks and approaches to pharmacotherapy. Endokrinologiya: novosti, mneniya, obucheniye. 2019; 8 (2): 57–66. DOI: 10.24411/2304-9529-2019-12007.
2. Potekhin NP, Sarkisov KA, Orlov FA et al. The effect of abdominal obesity on left ventricular myocardial remodeling in patients with arterial hypertension. Klinicheskaya meditsina. 2015; 7: 67–70.
3. Nyushko TY. Structural and functional changes of the left ventricle and vessels in patients with stage II hypertension, depending on the type of daily profile of blood pressure. Visnyk Vinnytskoho natsionalnoho medychnoho universytetu. 2015; 19 (2): 379–384.
4. Kologrivova IV, Vinnitsa IV, Koshelskaya OA, Suslova TE. Visceral obesity and cardiometabolic risk: features of hormonal and immune regulation. Ozhireniye i metabolizm. 2017; 14 (3): 3–10. DOI: 10.14341/omet201733-10.
5. Jayedi A, RashidyPour A, Khorshidi M, ShabBidar S. Body mass index, abdominal adiposity, weight gain and risk of developing hypertension: a systematic review and doseresponse meta-analysis of more than 2.3 million participants. Obes Rev. 2018; 19 (5): 654–667. DOI: 10.1111/obr.12656.